跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
QALSODY 100 MG SOLUCIÓN INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
QALSODY 100 MG SOLUCIÓN INYECTABLE
Approved
STANDARD
QALSODY 100 MG SOLUCIÓN INYECTABLE
Biogen Netherlands B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 14, 2024
Approval ID
0189eefff3cca073
Company
Biogen Netherlands B.V.
Type
Standard
Approval Details
Approval Id
0189eefff3cca073
Drug Cima Aemps Name
QALSODY 100 MG SOLUCIÓN INYECTABLE
Register Number
1231783001
Holder Company Name
Biogen Netherlands B.V.
Marketing Company Name
Biogen Spain S.L.
Holder Company Detail Path
/organization/biogen-netherlands-bv
Authorization Date
2024-06-14
Dosage Form
SOLUCIÓN INYECTABLE
Dose
100 mg
Route Of Administration
VÍA INTRATECAL
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Biogen Netherlands B.V.
Company Detail Path
/organization/biogen-netherlands-bv
Company Information
Pharmaceutical Company Name
Biogen Netherlands BV
Country Name
Netherlands
Website
http://www.biogen.nl
Active Ingredients
TOFERSEN
100 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 14, 2024
Approval ID
0189eefff3cca073
Type
Standard
Back to CIMA-AEMPS Approvals